IMMUNITAS Trademark

Trademark Overview

On Wednesday, December 18, 2019, a trademark application was filed for IMMUNITAS with the United States Patent and Trademark Office. The USPTO has given the IMMUNITAS trademark a serial number of 88984873. The federal status of this trademark filing is REGISTERED as of Tuesday, February 7, 2023. This trademark is owned by Immunitas Therapeutics, Inc.. The IMMUNITAS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases and disorders, and inflammatory diseases and disorders
immunitas

General Information

Serial Number88984873
Word MarkIMMUNITAS
Filing DateWednesday, December 18, 2019
Status700 - REGISTERED
Status DateTuesday, February 7, 2023
Registration Number6975007
Registration DateTuesday, February 7, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases and disorders, and inflammatory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 21, 2019
Primary Code005
First Use Anywhere DateFriday, September 30, 2022
First Use In Commerce DateFriday, September 30, 2022

Trademark Owner History

Party NameImmunitas Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameImmunitas Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameImmunitas Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Saturday, December 21, 2019NEW APPLICATION ENTERED
Saturday, December 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 17, 2020PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, March 17, 2020ASSIGNED TO EXAMINER
Tuesday, March 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 17, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 17, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 17, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, March 17, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, March 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 23, 2020ASSIGNED TO LIE
Wednesday, April 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 28, 2020PUBLISHED FOR OPPOSITION
Tuesday, April 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 23, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 16, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, December 16, 2020SOU EXTENSION 1 FILED
Wednesday, December 16, 2020SOU EXTENSION 1 GRANTED
Friday, December 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 21, 2021SOU TEAS EXTENSION RECEIVED
Monday, June 21, 2021SOU EXTENSION 2 FILED
Monday, June 21, 2021SOU EXTENSION 2 GRANTED
Wednesday, June 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 20, 2021SOU TEAS EXTENSION RECEIVED
Monday, December 20, 2021SOU EXTENSION 3 FILED
Monday, December 20, 2021SOU EXTENSION 3 GRANTED
Wednesday, December 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 6, 2022SOU TEAS EXTENSION RECEIVED
Friday, May 6, 2022SOU EXTENSION 4 FILED
Friday, May 6, 2022SOU EXTENSION 4 GRANTED
Tuesday, May 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 1, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, December 1, 2022SOU TEAS EXTENSION RECEIVED
Thursday, December 1, 2022TEAS REQUEST TO DIVIDE RECEIVED
Thursday, December 1, 2022SOU EXTENSION 5 FILED
Thursday, December 1, 2022DIVISIONAL REQUEST RECEIVED
Thursday, December 1, 2022USE AMENDMENT FILED
Thursday, December 29, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 29, 2022SOU EXTENSION 5 GRANTED
Thursday, December 29, 2022DIVISIONAL PROCESSING COMPLETE
Thursday, December 29, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, December 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 31, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 3, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 7, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, February 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

immunitas diseases disorders inflammatory autoimmune cancer preparations prevention treatment pharmaceutical